Back to Agenda
[V1-S4] The Changing Environment in the World and the Impact on the Pharmaceutical Industry
Session Chair(s)
Kihito Takahashi
Head of R&D/Medical Affairs Hub Japan, Swedish Orphan Biovitrium (SOBI) Japan, Japan
There was a worldwide impact event such as Brexit in EU and presidential election in US last year. This session is made up of 2 parts, the first part is Brexit. We would like to discuss the influence of Brexit for pharmaceutical companies in the world. On the other hand,” the international Summit of Heads of Medicines Regulatory Agencies” and” meeting of the International Coalition of Medicines Regulatory Authorities (ICMRA)” will convene for the first time in Japan, at the Kyoto in October and the representatives from a variety of countries and industries will discuss innovative technological developments and their practical applications, both current status and future expectations. In this session, we would like to confirm the movement in the world and discuss about the impacts and prospect in Japan.
Speaker(s)
Peter Bachmann
Retired from Head International Liaison Office and Conferences, Executive Depart, Federal Institute for Drugs and Medical Devices (BfArM), Germany
The Brexit and the Possible Implications for Marketing Authorisation Holders
Kazuhiko Mori, PHD, MSC
Business Manager, "Toyama, the Silicon Valley of Medicine" Creative Consortium Management Office, Japan
The Changing Environment in the World and the Impact on the Pharmaceutical Industry
Alberto Grignolo, PHD
Editor-in-Chief, DIA Global Forum, United States
Takuko Sawada
Director and Vice Chairperson of the Board, Shionogi & Co., Ltd., Japan
Tadaaki Taniguchi, MD, PHD
Executive Director and Strategic Officer, China Development, Emerging Market R&D, AstraZeneca K.K., Japan
Have an account?